Canadian application, no grantCanada
Pseudomonas aeruginosa antigens
CA 2392906 A1 · Owner: The University Of Canberra · Inventors: Thomas, Linda Diane; Kyd, Jennelle Maree; Cripps, Allan William
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Proteins derived from Pseudomonas aeruginosa are antigenic and are of use in the treatment, prophylaxis and diagnosis ofP.aeruginosa infection.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 4, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 4, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 4, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 4, 2000
GrantedNo grant recorded
Term endedDecember 4, 2020
Patent numberCA 2392906 A1
Classification (IPC)C12N15/31 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.